BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4208289)

  • 1. Pharmacokinetic studies of tobramycin and gentamicin.
    Simon VK; Mösinger EU; Malerczy V
    Antimicrob Agents Chemother; 1973 Apr; 3(4):445-50. PubMed ID: 4208289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.
    Traub WH; Raymond EA
    Appl Microbiol; 1972 Jan; 23(1):4-7. PubMed ID: 4621796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tobramycin and gentamicin.
    Britt MR; Garibaldi RA; Wilfert JN; Smith CB
    Antimicrob Agents Chemother; 1972 Sep; 2(3):236-41. PubMed ID: 4790564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL; Gramling PK; Vestal PR; Farrar WE
    Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1973 Jan; 3(1):87-94. PubMed ID: 4790579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1976 Aug; 10(2):382-3. PubMed ID: 825025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.
    Del Bene VE; Farrar WE
    Antimicrob Agents Chemother; 1972 Apr; 1(4):340-2. PubMed ID: 4670697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD; Young LS; Armstrong D
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME; Knight R; Kaye D
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory findings of tobramycin and their relation to clinical response.
    McAllister TA; Tait SC
    J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
    Forgan-Smith WR; Andrew JH; McSweeney RJ
    Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.
    Levison ME; Kaye D
    Antimicrob Agents Chemother; 1974 Jun; 5(6):667-9. PubMed ID: 15825423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.